FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Prescript Pharmaceuticals Chlorhexidine 0 Recall

Chlorhexidine 0

Prescript Pharmaceuticals, Inc. · Pleasanton, CA

Risk level
Class II
Reported by FDA
May 23, 2018
Recall ID
D-0807-2018
Check your lot numberHow we source this data

Summary

Prescript Pharmaceuticals recalled Chlorhexidine 0 starting Apr 24, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0807-2018 on May 23, 2018. Reason: Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F). Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Product description

Chlorhexidine 0.12% liquid, 473 MILLITERS. Rx Only. Mnfct for: XTTRUM Laboratories, Chicago, IL 60609. Mnfct by: pharmaceutical Assoiates, Inc., Greenville, SC 29605. Distrib by: PreScript Pharm. INC., Pleasanton, CA 94588. NDC: 00116-2001-16, Bar Code 1385-38-482

Lot numbers, UPCs & expiration codes

Lot # 130128, EXP 08/31/20

Where it was sold

California.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0807-2018
Classification
Class II
Status
Terminated
Recall initiated
Apr 24, 2018
FDA report date
May 23, 2018
Quantity
24 473-ml bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Prescript Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0807-2018, exactly as published.

Show all FDA fields
City
Pleasanton
State
CA
Status
Terminated
Country
United States
Event ID
79961
Address
39 California Ave Ste 104
Code information
Lot # 130128, EXP 08/31/20
Postal code
94566-6279
Report date
May 23, 2018
Product type
Drugs
Recall number
D-0807-2018
Classification
Class II
Recalling firm
Prescript Pharmaceuticals, Inc.
Product quantity
24 473-ml bottles
Termination date
Jan 23, 2019
Reason for recall
Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Chlorhexidine 0.12% liquid, 473 MILLITERS. Rx Only. Mnfct for: XTTRUM Laboratories, Chicago, IL 60609. Mnfct by: pharmaceutical Assoiates, Inc., Greenville, SC 29605. Distrib by: PreScript Pharm. INC., Pleasanton, CA 94588. NDC: 00116-2001-16, Bar Code 1385-38-482
Distribution pattern
California.
Recall initiation date
Apr 24, 2018
Initial firm notification
Letter
Center classification date
May 14, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0807-2018, published May 23, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls